Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Schnabl

Showing results (51-60 of 283) with videos related to

Pageof 29
Sort By:
Journal of Clinical and Experimental Hepatology|April 6, 2026
Establishing Region-specific Testing Strategies for Minimal Hepatic Encephalopathy: Lessons and Future Perspectives from a Young, Literate Indian CohortTakao Miwa, Masahito Shimizu, Bernd Schnabl
Alcohol Research : Current Reviews|March 28, 2025
Influence of Alcohol on the Intestinal Immune SystemHenriette Kreimeyer, Cristina Llorente, Bernd Schnabl
Translational Research : the Journal of Laboratory and Clinical Medicine|March 12, 2019
Role of the intestinal microbiome in liver fibrosis development and new treatment strategiesRongrong Zhou, Xuegong Fan, Bernd Schnabl
Clinical and Molecular Hepatology|December 16, 2025
Burden of malnutrition and sarcopenia in patients with cirrhosis: pathophysiology, assessment, and managementTakao Miwa, Masahito Shimizu, Bernd Schnabl
Cells|February 12, 2025
Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver DiseaseYifan Hu, Bernd Schnabl, Peter Stärkel
Toxins|March 6, 2021
Fungi-Bacteria Correlation in Alcoholic Hepatitis PatientsBei Gao, Xinlian Zhang, Bernd Schnabl
International Immunology|July 6, 2022
Liver cirrhosis and immune dysfunctionElda Hasa, Phillipp Hartmann, Bernd Schnabl
Liver Research|November 13, 2018
Gut microbiota, fatty liver disease, and hepatocellular carcinomaHuikuan Chu, Brandon Williams, Bernd Schnabl
Frontiers in Physiology|October 23, 2012
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver diseasePhillipp Hartmann, Wei-Chung Chen, Bernd Schnabl
Hepatology Communications|February 3, 2025
Peroxisome proliferator-activated receptor delta and liver diseasesTomoo Yamazaki, Edward E Cable, Bernd Schnabl
Pageof 29

Showing results (51-60 of 283) with videos related to

Sort By:
Pageof 29
Journal of Clinical and Experimental Hepatology|April 6, 2026
Establishing Region-specific Testing Strategies for Minimal Hepatic Encephalopathy: Lessons and Future Perspectives from a Young, Literate Indian CohortTakao Miwa, Masahito Shimizu, Bernd Schnabl
Alcohol Research : Current Reviews|March 28, 2025
Influence of Alcohol on the Intestinal Immune SystemHenriette Kreimeyer, Cristina Llorente, Bernd Schnabl
Translational Research : the Journal of Laboratory and Clinical Medicine|March 12, 2019
Role of the intestinal microbiome in liver fibrosis development and new treatment strategiesRongrong Zhou, Xuegong Fan, Bernd Schnabl
Clinical and Molecular Hepatology|December 16, 2025
Burden of malnutrition and sarcopenia in patients with cirrhosis: pathophysiology, assessment, and managementTakao Miwa, Masahito Shimizu, Bernd Schnabl
Cells|February 12, 2025
Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver DiseaseYifan Hu, Bernd Schnabl, Peter Stärkel
Toxins|March 6, 2021
Fungi-Bacteria Correlation in Alcoholic Hepatitis PatientsBei Gao, Xinlian Zhang, Bernd Schnabl
International Immunology|July 6, 2022
Liver cirrhosis and immune dysfunctionElda Hasa, Phillipp Hartmann, Bernd Schnabl
Liver Research|November 13, 2018
Gut microbiota, fatty liver disease, and hepatocellular carcinomaHuikuan Chu, Brandon Williams, Bernd Schnabl
Frontiers in Physiology|October 23, 2012
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver diseasePhillipp Hartmann, Wei-Chung Chen, Bernd Schnabl
Hepatology Communications|February 3, 2025
Peroxisome proliferator-activated receptor delta and liver diseasesTomoo Yamazaki, Edward E Cable, Bernd Schnabl
Pageof 29